1. Home
  2. Lan Xu
  3. Lan Xu

Primary tabs

Search
Limit to
Export 6 results:
Filters: Author is Lan Xu
2018
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials., Arbyn, M., and Xu Lan , Expert Rev Vaccines, 2018 Dec, Volume 17, Issue 12, (2018)
2017
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel., Polman, N J., Oštrbenk A, Xu Lan, Snijders P J. F., Meijer C J. L. M., Poljak M, Heideman D A. M., and Arbyn M. , J Clin Microbiol, 2017 Oct 11, (2017)
Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis., Arbyn, M., Xu Lan, Verdoodt Freija, Cuzick Jack, Szarewski Anne, Belinson Jerome L., Wentzensen Nicolas, Gage Julia C., and Khan Michelle J. , Ann Intern Med, 2017 Jan 17, Volume 166, Issue 2, p.118-127, (2017)
2016
Reply to HPV test results provide useful risk stratification information in women with ASC-H Pap test findings., Arbyn, M., Xu Lan, and Wentzensen Nicolas , Cancer, 2016 Oct, Volume 124, Issue 10, p.754-755, (2016)
Triage of ASC-H: A meta-analysis of the accuracy of high-risk HPV testing and other markers to detect cervical precancer., Xu, Lan, Verdoodt Freija, Wentzensen Nicolas, Bergeron Christine, and Arbyn M. , Cancer Cytopathol, 2016 Apr, Volume 124, Issue 4, p.261-72, (2016)
2013
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors (Protocol), Arbyn, M., Bryant A., Xu Lan, Simoens Cindy, and Markowitz L. , Cochrane Database Syst.Rev., 30/12/2013, Volume 12, Issue CD009069, Number 15, p.1 - 15, (2013)

QR code

QR code for this page URL